Table 3:
Drugs discussed in SARS/MERS Therapeutics papers that have not appeared in SARS-CoV-2 papers
| Drug | # of SARS/MERS Papers | Effective in SARS/MERS screening | Description |
|---|---|---|---|
| enfuvirtide | 5 | No | HIV fusion inhibito |
| Interferon alfacon-1 | 4 | Unclear | Interferons |
| hexachlorophene | 3 | Yes | Disinfectant |
| alendronic acid | 2 | Not relevant | Used for osteonecro |
| ethacrynic acid | 2 | Yes, for derivations | Loop diuretic |
| promazine | 2 | No | Antipsychotic |
| triclosan | 2 | No | Antibacterial/antifu |
| Interferon Alfa-2a, Recombinant | 1 | Unclear, with ribavirin | Interferons |
| L-phenylalanine | 1 | Yes, for derivations | Isomer of amino aci |
| Nitroprusside | 1 | No | Blood pressure med |
| Palivizumab | 1 | Not relevant | Monoclonal antibod RSV |
| adefovir dipivoxil | 1 | Not relevant | RTI for HepB |
| givosiran | 1 | Not relevant | Used for hepatic porphyria |
| loperamide | 1 | Yes | Diarrhea treatment |
| oritavancin | 1 | Yes | Antibiotic |
| phenazopyridine | 1 | Yes, for other coronaviruses | Analgesic |
| saracatinib | 1 | Yes | Kinase inhibitor |
| telavancin | 1 | Yes | Antibiotic |
| tobramycin | 1 | Not relevant | Antibiotic |